Speed to Market Mikart offers end to end CDMO services from development through manufacturing and packaging with a strong focus on speed and responsiveness, helping clients accelerate product launch. The mix of solid dose and non-sterile liquid capabilities, along with experience serving PhRMA, specialty pharma, and biotech, supports rapid commercialization.

Complex API Capabilities Mikart’s niche strengths include handling complex APIs and controlled substances, reinforced by collaborations in solubility enhancement and advanced coating technologies. This combination creates opportunities with biotech and specialty pharma clients that require compliant, scalable manufacturing for challenging molecules.

Capacity Upgrades Investment in manufacturing capacity, including modern tablet presses and facility expansions, positions Mikart to scale for high volume solid dose production across multiple programs while maintaining quality and regulatory readiness.

One Stop CDMO With development, analytical testing, manufacturing, and packaging offered under one roof, Mikart enables streamlined vendor management, shorter timelines, and cohesive program optimization for solid dose and non-sterile liquid products.

US Footprint Based in Atlanta with a growing US footprint and client base consisting of Biopharma, specialty pharma, and PhRMA members, Mikart offers a domestic, compliant partner ideal for customers prioritizing regulatory clarity, supply chain resilience, and timely QA cycles.